DE69816632D1 - Gegebenenfalls geschützte 3-hydroxymethylcarbapeneme und ihre synthese - Google Patents

Gegebenenfalls geschützte 3-hydroxymethylcarbapeneme und ihre synthese

Info

Publication number
DE69816632D1
DE69816632D1 DE69816632T DE69816632T DE69816632D1 DE 69816632 D1 DE69816632 D1 DE 69816632D1 DE 69816632 T DE69816632 T DE 69816632T DE 69816632 T DE69816632 T DE 69816632T DE 69816632 D1 DE69816632 D1 DE 69816632D1
Authority
DE
Germany
Prior art keywords
synthesis
hydroxymethylcarbapeneme
necessary protected
protected
necessary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69816632T
Other languages
English (en)
Other versions
DE69816632T2 (de
Inventor
Y Chung
L Leazer
Nobuyoshi Yasuda
S Jensen
M Wells
Chunhua Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9800459.1A external-priority patent/GB9800459D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE69816632D1 publication Critical patent/DE69816632D1/de
Publication of DE69816632T2 publication Critical patent/DE69816632T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69816632T 1997-08-26 1998-08-21 Gegebenenfalls geschützte 3-hydroxymethylcarbapeneme und ihre synthese Expired - Fee Related DE69816632T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5696797P 1997-08-26 1997-08-26
US56967P 1997-08-26
GBGB9800459.1A GB9800459D0 (en) 1998-01-09 1998-01-09 Crystalline 2-hydroxymethyl carbapenem intermediate compounds and process for synthesis thereof
GB9800459 1998-01-09
PCT/US1998/017467 WO1999010348A1 (en) 1997-08-26 1998-08-21 Optionally protected 3-hydroxymethyl carbapenems and synthesis

Publications (2)

Publication Number Publication Date
DE69816632D1 true DE69816632D1 (de) 2003-08-28
DE69816632T2 DE69816632T2 (de) 2004-06-03

Family

ID=26312921

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69816632T Expired - Fee Related DE69816632T2 (de) 1997-08-26 1998-08-21 Gegebenenfalls geschützte 3-hydroxymethylcarbapeneme und ihre synthese

Country Status (8)

Country Link
EP (1) EP1015452B1 (de)
JP (1) JP3386452B2 (de)
AT (1) ATE245647T1 (de)
AU (1) AU731494B2 (de)
CA (1) CA2301515A1 (de)
DE (1) DE69816632T2 (de)
ES (1) ES2202890T3 (de)
WO (1) WO1999010348A1 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99513A0 (en) * 1990-09-20 1992-08-18 Hoechst Ag Process for the preparation of carbapenem compounds

Also Published As

Publication number Publication date
AU731494B2 (en) 2001-03-29
WO1999010348A1 (en) 1999-03-04
JP2002503636A (ja) 2002-02-05
ES2202890T3 (es) 2004-04-01
EP1015452A4 (de) 2001-07-11
EP1015452A1 (de) 2000-07-05
JP3386452B2 (ja) 2003-03-17
EP1015452B1 (de) 2003-07-23
CA2301515A1 (en) 1999-03-04
ATE245647T1 (de) 2003-08-15
AU9115798A (en) 1999-03-16
DE69816632T2 (de) 2004-06-03

Similar Documents

Publication Publication Date Title
YU34896A (sh) Supstituisani n-(indol-2-karbonil)-glicinamidi, njihovi intermedijeri i farmaceutske kompozicije
ATE191485T1 (de) Mercaptoacetylamid-1,3,4,5- tetrahydrobenzo(c)azepin-3-ein disulfidderivate als enkephalinase und ace inhibitoren
YU11997A (sh) Laktamski derivati i njihove farmaceutske kompozicije
FI931888A0 (fi) Kramploesande cykliska fruktopyranossulfiter -och sulfater
DE69331089D1 (de) Beta-Laktam und Cepham Verbindungen und Ihre Herstellung
DE69705829D1 (de) Meta-substituierte phenylsulphonamidderivate
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
PT918776E (pt) Sintese total de acilfulvenos antitumorais
DE69717970T2 (de) Chinolin carbonsaure-derivate und ihre salze
DE69819727D1 (de) Stabilisierte carbapenem-zwischenprodukteund ihre verwendung in der synthese
GB9810659D0 (en) Organic compounds
ATE228520T1 (de) Lactamverbindungen als inhibitoren der cholesterin-esterase
DE69816632D1 (de) Gegebenenfalls geschützte 3-hydroxymethylcarbapeneme und ihre synthese
EP0987255A3 (de) Substituierte Aminochinazolinon (thion) Derivate
IL145869A0 (en) A process for the production of paclitaxel and novel paclitaxel derivatives
PL312471A1 (en) Benzene derivatives effective in ischaemia diseases
GB9523637D0 (en) Synthesis of carboxylic acid derivatives
AU7332996A (en) Therapeutics for thrombocytopenia
EP1005334A4 (de) Nervenschützende verbindungen und ihre verwendungen
MX9604347A (es) Derivados del acido 2-(4-pirazoliloxi-pirimidin-5-il) acetico.
ATE106871T1 (de) Pyridinderivate und verfahren zu ihrer synthese.
ATE176242T1 (de) Uck14-verbindungen
EP1104424A4 (de) Verfahren zur synthese von carbapenem-zwischenprodukten und hergestellte verbindungen
MX9706187A (es) Derivados de 3-pirrolidiliden-2-ona-cefalosporinas.
MX9303490A (es) Proceso para preaparar (1'r.3s 4r) 4-aciltio-azetidinonas.

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee